Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

David Becton

Concepts (167)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hemophilia A
2
2009
26
0.560
 Why?
Antineoplastic Combined Chemotherapy Protocols
6
2011
1020
0.490
 Why?
Leukemia, Myeloid, Acute
4
2010
202
0.380
 Why?
Osteosarcoma
2
2016
44
0.320
 Why?
Hematology
1
2009
24
0.310
 Why?
von Willebrand Diseases
1
2009
24
0.300
 Why?
Sclerotherapy
2
2020
47
0.300
 Why?
Antineoplastic Agents
5
2016
1216
0.280
 Why?
Vascular Malformations
2
2020
105
0.270
 Why?
Blood Coagulation Factor Inhibitors
1
2007
3
0.270
 Why?
Hemophilia B
1
2007
5
0.270
 Why?
Hemostasis, Surgical
1
2007
12
0.270
 Why?
Blood Coagulation Factors
1
2007
17
0.260
 Why?
Enoxaparin
1
2007
31
0.260
 Why?
Child, Preschool
13
2020
4046
0.260
 Why?
Blood Loss, Surgical
1
2007
70
0.260
 Why?
Venous Thrombosis
1
2007
89
0.240
 Why?
Cisplatin
3
2016
282
0.240
 Why?
Cyclosporine
1
2005
65
0.230
 Why?
Blood Coagulation Disorders
2
2020
41
0.230
 Why?
Hemostasis
2
2020
54
0.230
 Why?
Leukemia
1
2005
67
0.230
 Why?
Cladribine
1
2004
3
0.220
 Why?
Bone Regeneration
2
2016
70
0.220
 Why?
Histiocytosis, Langerhans-Cell
1
2004
32
0.210
 Why?
Retinoblastoma
1
2003
15
0.200
 Why?
Retinal Neoplasms
1
2003
13
0.200
 Why?
Infant
11
2018
3709
0.200
 Why?
Neoplasms
3
2012
1314
0.200
 Why?
Neoplasms, Second Primary
1
2003
75
0.190
 Why?
Child
14
2020
7194
0.190
 Why?
Bone Neoplasms
1
2003
188
0.170
 Why?
Thrombelastography
1
2020
27
0.170
 Why?
Adolescent
11
2020
6713
0.160
 Why?
Bleomycin
1
2018
36
0.140
 Why?
Down Syndrome
3
2008
92
0.140
 Why?
Antibiotics, Antineoplastic
1
2018
83
0.130
 Why?
Osteogenesis, Distraction
2
2016
78
0.130
 Why?
Piperazines
2
2016
125
0.130
 Why?
Leukemia, Megakaryoblastic, Acute
2
2006
5
0.120
 Why?
Leukemia, Myeloid
2
2008
41
0.120
 Why?
Humans
21
2020
52441
0.120
 Why?
Disease-Free Survival
5
2010
461
0.120
 Why?
Imidazoles
1
2016
114
0.110
 Why?
Male
13
2020
26874
0.110
 Why?
Remission Induction
4
2011
218
0.110
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2009
90
0.110
 Why?
Leukocyte Count
2
2005
71
0.110
 Why?
Receptors, Tumor Necrosis Factor, Type I
1
2013
38
0.100
 Why?
Survival Analysis
4
2010
656
0.100
 Why?
Doxorubicin
2
2005
246
0.100
 Why?
Cord Blood Stem Cell Transplantation
1
2011
9
0.090
 Why?
Neutropenia
1
2012
113
0.090
 Why?
Sarcoma, Myeloid
1
2011
20
0.090
 Why?
Heart Neoplasms
1
2011
30
0.090
 Why?
Treatment Outcome
7
2018
5508
0.080
 Why?
Core Binding Factors
1
2010
3
0.080
 Why?
Proto-Oncogene Proteins c-kit
1
2010
33
0.080
 Why?
Female
10
2020
28277
0.080
 Why?
Entamoebiasis
1
2009
2
0.080
 Why?
Diarrhea, Infantile
1
2009
5
0.080
 Why?
Liver Abscess
1
2009
5
0.080
 Why?
Listeriosis
1
2009
6
0.080
 Why?
Anemia, Aplastic
1
2009
10
0.080
 Why?
Platelet Transfusion
1
2009
33
0.080
 Why?
Histocompatibility Testing
1
2008
14
0.070
 Why?
Acute Lung Injury
1
2009
27
0.070
 Why?
Young Adult
5
2020
4346
0.070
 Why?
HLA Antigens
1
2008
55
0.070
 Why?
Abdominal Pain
1
2009
83
0.070
 Why?
Bone Marrow Transplantation
1
2008
110
0.070
 Why?
Hospitals, Pediatric
1
2009
241
0.070
 Why?
Retrospective Studies
6
2018
6694
0.070
 Why?
Adult
7
2020
14205
0.070
 Why?
Infusions, Intravenous
2
2004
212
0.060
 Why?
Cardiomyopathies
1
2008
117
0.060
 Why?
Mitolactol
1
2005
2
0.060
 Why?
GATA1 Transcription Factor
1
2005
7
0.060
 Why?
Karyotyping
1
2005
77
0.060
 Why?
Gene Expression Regulation, Neoplastic
2
2006
853
0.060
 Why?
Tamoxifen
1
2005
60
0.060
 Why?
Heart
1
2008
352
0.060
 Why?
Receptor Protein-Tyrosine Kinases
1
2004
51
0.050
 Why?
Proto-Oncogene Proteins
1
2004
146
0.050
 Why?
Immunosuppressive Agents
1
2005
248
0.050
 Why?
Humerus
1
2003
16
0.050
 Why?
Arkansas
1
2009
2013
0.050
 Why?
Mutation
2
2010
1331
0.050
 Why?
Tibia
1
2003
113
0.050
 Why?
Methotrexate
1
2003
76
0.050
 Why?
Survivors
1
2003
121
0.050
 Why?
Topotecan
1
2002
17
0.050
 Why?
Automation
1
2002
19
0.050
 Why?
Tumor Necrosis Factor-alpha
2
2013
390
0.040
 Why?
Dose-Response Relationship, Drug
1
2004
1365
0.040
 Why?
Blood Coagulation Tests
1
2020
18
0.040
 Why?
Blood Flow Velocity
1
2020
97
0.040
 Why?
Blood Coagulation
1
2020
64
0.040
 Why?
Follow-Up Studies
2
2018
2294
0.040
 Why?
Prognosis
3
2012
2100
0.040
 Why?
Mice, Inbred C57BL
2
2016
1888
0.040
 Why?
Gene Expression Profiling
1
2004
1099
0.040
 Why?
Hemorrhage
1
2020
225
0.040
 Why?
Daunorubicin
2
2008
13
0.030
 Why?
Cytarabine
2
2006
42
0.030
 Why?
Mice, Nude
1
2016
230
0.030
 Why?
Xenograft Model Antitumor Assays
1
2016
218
0.030
 Why?
Random Allocation
1
2016
286
0.030
 Why?
Acute Disease
2
2008
384
0.030
 Why?
Cluster Analysis
2
2005
236
0.030
 Why?
Prospective Studies
2
2012
2433
0.030
 Why?
Oligonucleotide Array Sequence Analysis
2
2005
412
0.030
 Why?
Interleukin-3
1
2012
12
0.020
 Why?
Calcitonin Gene-Related Peptide
1
2012
24
0.020
 Why?
Protein Precursors
1
2012
45
0.020
 Why?
Calcitonin
1
2012
30
0.020
 Why?
Sensitivity and Specificity
2
2006
871
0.020
 Why?
Interleukin-8
1
2012
86
0.020
 Why?
Interleukin-10
1
2012
81
0.020
 Why?
ROC Curve
1
2012
249
0.020
 Why?
Fatal Outcome
1
2011
193
0.020
 Why?
Mice, Knockout
1
2013
903
0.020
 Why?
Interleukin-6
1
2012
271
0.020
 Why?
Intensive Care Units
1
2012
235
0.020
 Why?
Animals
2
2016
13485
0.020
 Why?
Pilot Projects
1
2012
725
0.020
 Why?
Exons
1
2010
101
0.020
 Why?
Time Factors
2
2008
2987
0.020
 Why?
Opportunistic Infections
1
2009
56
0.020
 Why?
Echocardiography
1
2011
409
0.020
 Why?
Translocation, Genetic
1
2010
266
0.020
 Why?
Mitoxantrone
1
2008
9
0.020
 Why?
Hospitalization
1
2012
731
0.020
 Why?
Proportional Hazards Models
1
2008
446
0.020
 Why?
Recurrence
1
2008
680
0.020
 Why?
Genetic Predisposition to Disease
1
2010
525
0.020
 Why?
Prevalence
1
2010
1016
0.020
 Why?
Immunophenotyping
1
2006
115
0.020
 Why?
Tomography, X-Ray Computed
1
2011
1140
0.020
 Why?
Luciferases
1
2005
50
0.010
 Why?
Nucleic Acid Hybridization
1
2005
54
0.010
 Why?
Diagnosis, Differential
1
2009
1028
0.010
 Why?
Cell Membrane
1
2006
238
0.010
 Why?
DNA Primers
1
2005
204
0.010
 Why?
Middle Aged
1
2020
13133
0.010
 Why?
Transfection
1
2005
365
0.010
 Why?
Tumor Cells, Cultured
1
2005
441
0.010
 Why?
Core Binding Factor Alpha 3 Subunit
1
2004
1
0.010
 Why?
Magnetic Resonance Imaging
1
2011
1507
0.010
 Why?
fms-Like Tyrosine Kinase 3
1
2004
20
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
580
0.010
 Why?
Benzamides
1
2004
52
0.010
 Why?
Risk Assessment
1
2008
1349
0.010
 Why?
Mice
1
2013
5899
0.010
 Why?
Risk Factors
1
2012
3971
0.010
 Why?
Pyrimidines
1
2004
199
0.010
 Why?
Nuclear Proteins
1
2004
247
0.010
 Why?
DNA Helicases
1
2004
147
0.010
 Why?
DNA-Binding Proteins
1
2004
423
0.010
 Why?
Predictive Value of Tests
1
2004
938
0.010
 Why?
Drug Administration Schedule
1
2002
370
0.010
 Why?
Linear Models
1
2002
288
0.010
 Why?
Neutrophils
1
2002
148
0.010
 Why?
Transcription Factors
1
2004
570
0.010
 Why?
Analysis of Variance
1
2002
558
0.010
 Why?
Patient Selection
1
2002
269
0.010
 Why?
Infant, Newborn
1
2006
2871
0.010
 Why?
Becton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (167) concept(s)
_
Co-Authors Expand Description
See all (14) people
_
Similar People Expand Description
See all (33) people
_
Same Department Expand Description
Search Department